Table of Content

Table of content

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
Chapter 2 Executive Summary
2.1 Competition Milieu
2.2 Market Snapshot
2.3 Segment Outlook
Chapter 3 Market Variables, Trends, & Scope
3.1 Penetration & Growth Prospect Mapping for Therapy Type, 2018
3.2 T-Cell Therapy - Market Dynamics
3.2.1 Market driver analysis
3.2.1.1 Rising investment in adoptive T cell transfer approaches of disease treatment
3.2.1.2 Growing competition among market players
3.2.1.3 Approval of Kymriah and Yescarta across various countries
3.2.1.4 Developments in CAR T-cell therapy for solid tumors
3.2.1.5 Technological advancements in manufacturing process
3.2.2 Market restraint analysis
3.2.2.1 Regulatory, scientific, and ethical challenges associated with gene therapy
3.2.2.2 High prices of therapies
3.2.2.3 CAR T limitations
3.2.3 Opportunity analysis
3.2.3.1 Facility expansion for cell and gene therapies
3.2.3.2 Rising global financings in gene and cell therapy arena
3.2.3.3 Ongoing developments in viral & non-viral vector manufacturing arena
3.3 Regulatory Landscape
3.3.1 Current and potential future approvals
3.3.2 Frameworks for risk mitigation and safety monitoring
3.3.3 Regulatory framework, by geography
3.3.3.1 U.S.
3.3.3.2 Europe
3.3.3.3 China
3.3.3.4 Japan
3.4 Pricing and Payment Models for Adoptive Cellular Therapies (ACT)
3.4.1 Insurance coverage
3.4.2 Value-based price benchmarks
3.4.3 Alternate payment strategies
3.5 Patent Landscape
3.6 Deals, Funding’s, Partnerships and Collaborations
3.6.1 Licensing deals
3.6.2 Merger & acquisition deals
3.6.3 Collaboration & partnerships
3.7 Pipeline Analysis
3.7.1 Clinical trial landscape
3.8 Geographic Mapping of Companies
3.9 Competitive Landscape for CD19?directed CAR?T Therapies and Other T-cell therapies
3.10 T-cell Therapy Market-SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.10.1 Political landscape
3.10.2 Economic landscape
3.10.3 Social landscape
3.10.4 Technology landscape
3.11 Industry Analysis - Porter’s
3.11.1 Supplier bargaining power
3.11.2 Buyer bargaining power
3.11.3 Substitution threat
3.11.4 Threat from new entrant
3.11.5 Competitive rivalry
Chapter 4 T-cell Therapy Market: Modality Estimates & Trend Analysis
4.1 T-cell Therapy Market: Modality Movement Analysis
4.2 Research
4.2.1 Global research-based T-cell therapy market, 2015 - 2026 (USD Million)
4.3 Commercialized
4.3.1 Global commercial T-cell therapy market, 2015 - 2026 (USD Million)
Chapter 5 T-cell Therapy Market Categorization: Therapy Type Estimates & Trend Analysis
5.1 T-cell Therapy Market: Therapy Type Movement Analysis
5.2 CAR T-cell Therapy
5.2.1 Global CAR T-cell Therapy market, 2015 - 2026 (USD Million)
5.3 T Cell Receptor (TCR)-based
5.3.1 Global T Cell Receptor (TCR)-based therapy market, 2015 - 2026 (USD Million)
5.4 Tumor Infiltrating Lymphocytes (TIL)-based
5.4.1 Global Tumor Infiltrating Lymphocytes (TIL)-based therapy market, 2015 - 2026 (USD Million)
Chapter 6 T-cell Therapy Market Categorization: Indication Estimates & Trend Analysis
6.1 T-cell Therapy Market: Indication Movement Analysis
6.2 Hematologic Malignancies
6.2.1 Global T-cell therapy market for hematologic malignancies, 2015 - 2026 (USD Million)
6.2.2 Lymphoma
6.2.2.1 Global T-cell therapy market for lymphoma, 2015 - 2026 (USD Million)
6.2.3 Leukemia
6.2.3.1 Global T-cell therapy market for leukemia, 2015 - 2026 (USD Million)
6.2.4 Myeloma
6.2.4.1 Global T-cell therapy market for myeloma, 2015 - 2026 (USD Million)
6.3 Solid Tumors
6.3.1 Global T-cell therapy market for solid tumors, 2015 - 2026 (USD Million)
6.3.2 Melanoma
6.3.2.1 Global T-cell therapy market for melanoma, 2015 - 2026 (USD Million)
6.3.3 Brain & Central Nervous System
6.3.3.1 Global T-cell therapy market for brain & central nervous system, 2015 - 2026 (USD Million)
6.3.4 Liver cancer
6.3.4.1 Global T-cell therapy market for liver cancer, 2015 - 2026 (USD Million)
6.3.5 Others
6.3.5.1 Global T-cell therapy market for other cancer forms, 2015 - 2026 (USD Million)
Chapter 7 T-cell Therapy Market Categorization: Regional Estimates & Trend Analysis, by Use-type & Therapy Type
7.1 T-cell Therapy Market Share by Regional, 2018 & 2026
7.2 North America
7.2.1 North America T-cell therapy market, 2015 - 2026 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. T-cell therapy market, 2015 - 2026 (USD Million), by modality
7.2.2.2 U.S. T-cell therapy market, 2015 - 2026 (USD Million), by therapy type
7.2.2.3 U.S. T-cell therapy market, 2015 - 2026 (USD Million), by indication
7.2.3 Canada
7.2.3.1 Canada T-cell therapy market, 2015 - 2026 (USD Million), by modality
7.2.3.2 Canada T-cell therapy market, 2015 - 2026 (USD Million), by therapy type
7.2.3.3 Canada T-cell therapy market, 2015 - 2026 (USD Million), by indication
7.3 Europe
7.3.1 Europe T-cell therapy market, 2015 - 2026 (USD Million)
7.3.2 Germany
7.3.2.1 Germany T-cell therapy market, 2015 - 2026 (USD Million), by modality
7.3.2.2 Germany T-cell therapy market, 2015 - 2026 (USD Million), by therapy type
7.3.2.3 Germany T-cell therapy market, 2015 - 2026 (USD Million), by indication
7.3.3 U.K.
7.3.3.1 U.K. T-cell therapy market, 2015 - 2026 (USD Million), by modality
7.3.3.2 U.K. T-cell therapy market, 2015 - 2026 (USD Million), by therapy type
7.3.3.3 U.K. T-cell therapy market, 2015 - 2026 (USD Million), by indication
7.4 Asia Pacific
7.4.1 Asia Pacific T-cell therapy market, 2015 - 2026 (USD Million)
7.4.2 Japan
7.4.2.1 Japan T-cell therapy market, 2015 - 2026 (USD Million), by modality
7.4.2.2 Japan T-cell therapy market, 2015 - 2026 (USD Million), by therapy type
7.4.2.3 Japan T-cell therapy market, 2015 - 2026 (USD Million), by indication
7.4.3 China
7.4.3.1 China T-cell therapy market, 2015 - 2026 (USD Million), by modality
7.4.3.2 China T-cell therapy market, 2015 - 2026 (USD Million), by therapy type
7.4.3.3 China T-cell therapy market, 2015 - 2026 (USD Million), by indication
7.5 Latin America
7.5.1 Latin America T-cell therapy market, 2015 - 2026 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil T-cell therapy market, 2015 - 2026 (USD Million), by modality
7.5.2.2 Brazil T-cell therapy market, 2015 - 2026 (USD Million), by therapy type
7.5.2.3 Brazil T-cell therapy market, 2015 - 2026 (USD Million), by indication
7.6 MEA
7.6.1 MEA T-cell therapy market, 2015 - 2026 (USD Million)
7.6.2 South Africa
7.6.2.1 Brazil T-cell therapy market, 2016 - 2026 (USD Million), by modality
7.6.2.2 Brazil T-cell therapy market, 2016 - 2026 (USD Million), by therapy type
7.6.2.3 Brazil T-cell therapy market, 2016 - 2026 (USD Million), by indication
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Company Profiles
8.2.1 Novartis AG
8.2.1.1 Company overview
8.2.1.1.1 AveXis, Inc.
8.2.1.2 Financial performance
8.2.1.3 Product benchmarking
8.2.1.4 Strategic initiatives
8.2.2 Gilead Sciences
8.2.2.1 Company overview
8.2.1.1.1 Kite Pharma
8.2.2.2 Financial performance
8.2.2.3 Product benchmarking
8.2.2.4 Strategic initiatives
8.2.3 bluebird bio, Inc.
8.2.3.1 Company overview
8.2.3.2 Financial performance
8.2.3.3 Product benchmarking
8.2.3.4 Strategic initiatives
8.2.4 TCR2 Therapeutics Inc
8.2.4.1 Company overview
8.2.4.2 Financial performance
8.2.4.3 Product benchmarking
8.2.4.4 Strategic initiatives
8.2.5 Sorrento Therapeutics
8.2.5.1 Company overview
8.2.5.2 Product benchmarking
8.2.5.3 Strategic initiatives
8.2.6 Fate Therapeutics
8.2.6.1 Company overview
8.2.6.2 Financial performance
8.2.6.3 Product benchmarking
8.2.6.3 Strategic initiatives
8.2.7 Merck KGaA
8.2.7.1 Company overview
8.2.7.2 Financial performance
8.2.7.3 Product benchmarking
8.2.7.3 Strategic initiatives
8.2.8 Pfizer Inc.
8.2.8.1 Company overview
8.2.8.2 Financial performance
8.2.8.3 Product benchmarking
8.2.8.4 Strategic initiatives
8.2.9 Amgen
8.2.9.1 Company overview
8.2.9.2 Financial performance
8.2.9.3 Product benchmarking
8.2.9.4 Strategic initiatives
8.2.10 Celgene Corporation
8.2.10.1 Company overview
8.2.1.1.1 Juno Therapeutics
8.2.10.2 Financial performance
8.2.10.3 Product benchmarking
8.2.10.4 Strategic initiatives



List of Tables



TABLE 1 Summary of finalized, proposed, and modeled payment adjustments, 2019 - 2023
TABLE 2 Licensing deals in T-cell therapy space
TABLE 3 Merger & acquisition deals in T-cell therapy space
TABLE 4 Collaboration & partnerships in T-cell therapy space
TABLE 5 CAR T-cell target antigens in US trials
TABLE 6 CAR T-cell target antigens in China trials
TABLE 7 Competitive landscape for CD 19-directed CAR T Therapies in r/r lymphoma and leukemia
TABLE 8 CAR T-cell targets under investigation for hematologic malignancies
TABLE 9 North America T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 10 North America T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 11 North America T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 12 North America T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 13 North America T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 14 U.S. T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 15 U.S. T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 16 U.S. T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 17 U.S. T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 18 U.S. T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 19 Canada T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 20 Canada T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 21 Canada T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 22 Canada T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 23 Canada T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 24 Europe T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 25 Europe T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 26 Europe T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 27 Europe T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 28 Europe T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 29 Germany T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 30 Germany T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 31 Germany T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 32 Germany T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 33 Germany T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 34 U.K. T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 35 U.K. T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 36 U.K. T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 37 U.K. T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 38 U.K. T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 39 Asia Pacific T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 40 Asia Pacific T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 41 Asia Pacific T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 42 Asia Pacific T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 43 Asia Pacific T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 44 Japan T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 45 Japan T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 46 Japan T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 47 Japan T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 48 Japan T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 49 China T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 50 China T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 51 China T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 52 China T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 53 China T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 54 Latin America T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 55 Latin America T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 56 Latin America T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 57 Latin America T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 58 Latin America T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 59 Brazil T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 60 Brazil T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 61 Brazil T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 62 Brazil T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 63 Brazil T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 64 MEA T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 65 MEA T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 66 MEA T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 67 MEA T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 68 MEA T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 69 South Africa T-cell therapy market estimates & forecasts, by modality, 2015 - 2026 (USD Million)
TABLE 70 South Africa T-cell therapy market estimates & forecasts, by therapy-type, 2015 - 2026 (USD Million)
TABLE 71 South Africa T-cell therapy market estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 72 South Africa T-cell therapy market for hematologic malignancies estimates & forecasts, by indication, 2015 - 2026 (USD Million)
TABLE 73 South Africa T-cell therapy market for solid tumors estimates & forecasts, by indication, 2015 - 2026 (USD Million)